Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves

Journal of Clinical Investigation

Volumn 99, Issue 5, 1997, Pages 996-1009

  Srivatsa, S S ^a   Harrity, P J ^a   Maercklein, P B ^a   Kleppe, L ^a   Veinot, J ^a   Edwards, W D ^a   Johnson, C M ^a   Fitzpatrick, L A ^a  

^a MAYO CLINIC   (United States)

Author keywords

calcification; heart valves; in situ hybridization; noncollagenous matrix proteins; osteopontin

Indexed keywords

MATRIX PROTEIN; MESSENGER RNA; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN;

ANIMAL TISSUE; ARTICLE; CALCIFICATION; CELL INFILTRATION; CELLULAR DISTRIBUTION; HEART VALVE BIOPROSTHESIS; HEART VALVE REPLACEMENT; HEART VALVE STENOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; MINERALIZATION; NONHUMAN; PRIORITY JOURNAL; PROSTHESIS FAILURE; PROTEIN EXPRESSION;

EID: 0030907873     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119265     Document Type: Article

References (68)

1. Schoen, F.J., R.J. Levy, and H.R. Piehler. 1992. Pathological considerations in replacement heart valves. Cardiovasc. Pathol. 1:29-52.
2. O'Keefe, J.H., C.J. Lavie, R.A. Nishimura, and W.D. Edwards. 1991. Degenerative aortic stenosis. Postgrad. Med. 89:143-154.
3. Roberts, W.C. 1977. The congenitally bicuspid aortic valve. A study of 85 autopsy cases. Am. J. Cardiol. 26:72-83.
4. Sell, S., and R.E. Scully. 1965. Aging changes in the aortic and mitral valves. Histologic and histochemical studies, with observations on the pathogenesis of calcific aortic stenosis and calcification of the mitral annulus. Am. J. Pathol. 46:345-355.
5. Mills, P., G. Leech, M. Davies, and A. Leatham. 1978. The natural history of the non-stenotic aortic valve. Br. Heart J. 40:951-957.
6. Kim, K.M., J.M. Valigorsky, W.J. Mergner, R.T. Jones, R.F. Pendergrass, and B.F. Trump. 1976. Aging changes in the human aortic valve in relation to dystrophic calcification. Hum. Pathol. 7:47-60
7. Schoen, F.J., H. Harasaki, K.M. Kim, H.C. Anderson, and R.J. Levy. 1988. Biomaterial associated calcification: pathology, mechanisms, and strategies for prevention. J. Biomed. Mater. Res. 22(Suppl. A1):11-36.
8. Schoen, F.J., and C.E. Hobson. 1985. Anatomic analysis of removed prosthetic heart valves: causes of failure of 33 mechanical valves and 58 bioprostheses 1980-1983. Hum. Pathol. 16:549-559.
9. Schoen, F.J., J. Kujovitch, R.J. Levy, and M.S. Sutton. 1988. Bioprosthetic valve failure. Cardiovasc. Clin. 18:289-317.
10. Schoen, F.J. 1987. Cardiac valve prostheses: review of clinical status and contemporary biomaterials issues. J. Biomed. Mater. Res. 21(Suppl. A1):91-117.
11. Pernmanyer-Miralda, G., J. Soler-Soler, J.M. Casan-Cava, and M.P. Tornos-Mas. 1980. Medium term fate of dura mater valvular bioprostheses. Eur. Heart J. 1:195-199.
12. Allen, D.J., G.J. Highison, L.J. Didio, E.J. Zerbini, and L.B. Puig. 1982. Evidence of remodeling in dura mater cardiac valves. J. Thorac. Cardiovasc. Surg. 84:267-281.
13. Schoen, F.J. 1987. Cardiac valve prostheses. Pathologic and bioengineering considerations. J. Cardiac Surg. 2:65-108.
14. Hilbert, S.L., V.J. Ferrans, Y. Tomita, E.E. Eidbo, and M. Jones. 1987. Evaluation of explanted polyurethane trileaflet cardiac valve prostheses. J. Thorac. Cardiovasc. Surg. 94:419-429.
15. Harasaki, H., J. McMahon, T. Richards, J. Goldcamp, R. Kiraly, and Y. Nose. 1985. Calcification in cardiovascular implants: degraded cell related phenomena. Trans. Am. Soc. Artif. Intern. Org. 31:489-494.
16. Glimcher, M.J. 1981. On the form and function of bone: from molecules to organs. Wolff's law revisited. In The Chemistry and Biology of Mineralized Connective Tissues. A. Veis, editor. Elsevier/North-Holland, Amsterdam. 617.
17. Levy, R.J., F.J. Schoen, J.T. Levy, A.C. Nelson, S.L. Howard, and L.J. Oshry. 1983. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am. J. Pathol. 113:143-155.
18. Fitzpatrick, L.A., A. Severson, W.D. Edwards, and R.T. Ingram. 1994. Diffuse calcification associated with noncollagenous matrix protein expression in human atherosclerotic coronary arteries. Implication for the formation of calcified plaque. J Clin. Invest. 94:1597-1604.
19. Ikeda, T., T. Shirasawa, Y. Esaki, S. Yoshiki, and K. Hirokawa. 1993. Osteopontin mRNA is expressed by smooth muscle derived foam cells in human atherosclerotic lesions of the aorta. J. Clin. Invest. 92:2814-2820.
20. Robey, P.G., N.S. Fedarko, T.E. Hefferan, P. Bianco, U.K. Vetter, W. Grzesik, A. Friedenstein, G. Van Der Pluijm, K.P. Mintz, M.F. Young, et al. 1993. Structure and molecular regulation of bone matrix proteins. J. Bone Miner. Res. 8:S483-S487.
21. Takano-Yamamoto, T., T. Takemura, Y. Kitamura, and S. Nomura. 1994. Site specific expression of mRNA's for osteonectin, osteocalcin, and osteopontin revealed by in situ hybridization in rat periodontal ligament during physiologic tooth. J. Histochem. Cytochem. 42:885-896.
22. Giachelli, C.M., N. Bae, M. Almeida, D.T. Denhardt, C.E. Alpers, and S.M. Schwartz. 1993. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J. Clin. Invest. 92:1686-1696.
23. Böstrom, K., K.E. Watson, S. Horn, C. Wortham, I.M. Herman, and L.L. Demer. 1993. Bone morphogenetic protein expression in human atherosclerotic lesions. J. Clin. Invest. 91:1800-1809.
24. Demer, L. 1995. A skeleton in the atherosclerosis closet. Circulation. 92: 2029-2032.
25. Kim, K.M. 1976. Calcification of matrix vesicles in human aortic valve and aortic media. Fed. Proc. 35:156-162.
26. Ingram, R.T., Y.K. Park, B.T. Clarke, and L.A. Fitzpatrick. 1994. Age-and gender-related changes in the distribution of osteocalcin in the extracellular matrix of normal hone and female bone. Possible involvement of osteocalcin in bone remodeling. J. Clin. Invest. 93:989-997.
27. Ingram, R.T., B.T. Clarke, L.W. Fisher, and L.A. Fitzpatrick. 1993. Distribution of noncollagenous proteins in the matrix of adult human bone: evidence of anatomic and functional heterogeneity. J. Bone Miner. Res. 8:1019-1029.
28. Stein, G., and J. Lian. 1993. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr. Rev. 14:424-442.
29. Bosse, A., P. Wuisman, D.B. Jones, and K. Schwarz. 1993. Noncollagenous proteins in heterotopic ossification. Immunohistochemical analysis in 15 paraplegics. Acta Orthop. Scand. 64:634-638.
30. Fisher, L.W., J.T. Stubbs III, and M.F. Young. 1995. Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop. Scand. 66(Suppl. 266):61-65.
31. McKee, M.D., A. Nanci, W.J. Landis, Y. Gotoh, L.C. Gerstenfeld, and M.J. Glimcher. 1991. Effects of fixation and demineralization on the retention of bone phosphoprotein and other matrix components as evaluated by biochemical analyses and quantitative immunocytochemistry. J. Bone Miner. Res. 6:937-945.
32. Giachelli, C.M., L. Liaw, C.E. Murry, S.M. Schwartz, and M. Almeida. 1995. Osteopontin expression in cardiovascular diseases. Ann. NY Acad. Sci. 760:109-126.
33. Price, P.A. 1985. Vitamin K-dependent formation of bone Gla protein (osteocalcin) and its function. Vitam. Horm. 42:65-107.
34. Roach, H.I. 1994. Why does bone matrix contain noncollagenous proteins? The possible roles of osteocalcin, osteonectin, osteopontin, and bone sialoprotein in bone mineralization and resorption. Cell Biol. Int. 18:617-628.
35. Olsson, M., M. Rosenqvist, and J. Nilsson. 1994. Expression of HLA-DR antigen and smooth muscle cell differentiation markers by valvular fibroblasts in degenerative aortic stenosis. J. Am. Coll. Cardiol. 24:1664-1671.
36. Levy, R.J., F.J. Schoen. and S.L. Howard. 1983. Mechanism of calcification of porcine bioprosthetic aortic valve cusps: role of T-lymphocytes. Am. J. Cardiol. 52:629-631.
37. Dahm, M., W.D. Lyman, A.B. Schwell, S.M. Factor, and R.W. Frater. 1990. Immunogenicity of glutaraldehyde-tanned bovine pericardium. J. Thorac. Cardiovasc. Surg. 99:1082-1090.
38. Olsson, M., C.-J. Dalsgaard, A. Haegerstrand, M. Rosenqvist, L. Ryden, and J. Nilsson. 1994. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J. Am. Coll. Cardiol. 23:1162-1170.
39. Patarca, R., R.A. Saavedra, and H. Cantor. 1993. Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene. Crit. Rev. Immunol. 13:225-246.
40. Weber, G.F., S. Ashkar, M.J. Glimcher, and H. Cantor. 1996. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science (Wash. DC). 271:509-512.
41. Hirota, S., M. Imakita, K. Kohri, A. Ito, E. Morii, S. Adachi, H.M. Kim, Y. Kitamura, C. Yutani, and S. Nomura. 1993. Expression of osteopontin messenger mRNA by macrophages in atherosclerotic plaques. A possible association with calcification. Am. J. Pathol. 143:1003-1008.
42. O'Brien, E.R., M.R. Garvin, D.K. Stewart, T. Hinohara, J.B. Simpson, S.M. Schwartz, and C.M. Giachelli. 1994. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler. Thromb. 14:1648-1656.
43. Severson, A.R., R.T. Ingram, and L.A. Fitzpatrick. 1995. Matrix proteins associated with bone calcification are present in human vascular smooth muscle cells grown in vitro. In Vitro Cell. Dev. Biol. Animal. 31:853-857.
44. Gadeau, A., M. Campan, D. Millet, T. Candresse, and C. Desgranges. 1993. Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in-vitro. Arterioscler. Thromb. 13:120-125.
45. O'Brien, E.R., M.R. Garvin, D.K. Stewart, T. Hinohara, J.B. Simpson, S.M. Schwartz, and C.M. Giachelli. 1994. Osteopontin is synthesized by macrophage, smooth muscle and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler. Thromb. 14:1648-1656.
46. Shanahan, C.M., R.B. Cary, J.C. Metcalfe, and P. Weissberg. 1994. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J. Clin. Invest. 93:2393-2402.
47. Srivatsa, S.S., R.S. Schwartz, D.R. Holmes, Jr., W.D. Edwards, Y.-K. Park, and L.A. Fitzpatrick. 1994. Coronary artery injury markedly upregulates matrix protein mRNA following experimental balloon angioplasty. Clin. Res. 42:180a. (Abstr.)
48. Watson, K.E., K. Bostrom, R. Ravindranath, T. Lam, B. Norton, and L.L. Demer. 1994. TGF-β1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J. Clin. Invest. 93:2106-2113.
49. Miyazaki, Y., M. Setoguchi, S. Yoshida, Y. Higuchi, S. Akizuki, and S. Yamamoto. 1990. The mouse osteopontin gene: expression in monocytic ineages and complete nucleotide sequences. J. Biol. Chem. 265:14432-14438.
50. Denhardt, D.T., and X. Guo. 1993. Osteopontin: a protein with diverse functions. FASEB (Fed. Am. Soc. Exp. Biol.) J. 7:1475-1482.
51. 3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. Circ. Res. 77:665-672.
52. Liaw, L., M.P. Skinner, E.W. Raines, R. Ross, D.A. Cheresh, S.M. Schwartz, and C.M. Giachelli. 1995. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. J. Clin. Invest. 95:713-724.
53. Hu, D.D., E.C. Lin, N.L. Kovach, J.R. Hoyer, and J.W. Smith. 1995. A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5. J. Biol. Chem. 270:26232-26238.
54. Singh, R.P., R. Patarca, J. Schwartz, P. Singh, and H. Cantor. 1990. Definition of a specific interaction between the early T lymphocyte activation-1 (Eta-1) protein and murine macrophages in vitro and its effects upon macrophages in vivo. J. Exp. Med. 181:1931-1942.
55. Giachelli, CM., S.M. Schwartz, and L. Liaw. 1995. Molecular and cellular biology of osteopontin. Potential role in cardiovascular disease. Trends Cardiovasc. Med. 5:88-95.
56. Liaw, L., M. Almeida, C. Hart, S.M. Schwartz, and C.M. Giachelli. 1994. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ. Res. 74:214-224.
57. 3 potentiate bone resorption. J. Biol. Chem. 268:9901-9907.
58. O'Brien, K.D., J. Kuusisto, D.D. Reichenbach, M. Ferguson, C. Giachelli, C.E. Alpers, and C.M. Otto. 1995. Osteopontin is expressed in human aortic valvular lesions. Circulation. 92:2163-2168.
59. Thiede, M.A., S.L. Smock, D.N. Peterson, W.A. Grasser, D.D. Thompson, and S.K. Nishimoto. 1994. Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets. Endocrinology. 135:929-937.
60. Stenner, D.D., R.P. Tracy, B.L. Riggs, and K.G. Mann. 1985. Human platelets contain and secrete osteonectin, a major protein of mineralized bone. Proc. Natl. Acad. Sci. USA. 82:2267-2271.
61. Raines, E.W., T.F. Lane, M.L. Iruela-Arispe, R. Ross, and E.H. Sage. 1992. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc. Natl. Acad. Sci. USA. 89:1281-1285.
62. Jundt, G., K.H. Berghauser, J.D. Termine, and A. Schulz. 1987. Osteonectin: a differentiation marker of bone cells. Cell. Tissue Res. 248:409-115.
63. Tremble, P.M., T.F. Lane, E.H. Sage, and Z. Werb. 1993. SPARC, a secreted protein associated with morphogenesis and tissue remodeling, induces expression of metalloproteinase in fibroblasts through a novel extracellular matrix dependent pathway. J. Cell Biol. 121:1433-1444.
64. Levy, R.J., J.A. Zenker, and W.F. Benhard. 1983. Porcine bioprosthetic valve calcification in bovine left ventricle-aorta shunts: studies of the deposition of vitamin K-dependent proteins. Ann. Thorac. Surg. 36:187-192.
65. Levy, R.J., C. Gundberg, and R. Scheinman. 1983. The identification of the vitamin K dependent bone protein osteocalcin as one of the γ-carboxyglutamic acid containing proteins present in calcified atherosclerotic plaque and mineralized heart valves. Atherosclerosis. 46:49-56.
66. Levy, R.J., J.A. Zenker, and J.B. Lian. 1980. Vitamin K-dependent calcium binding proteins in aortic valve calcification. J. Clin. Invest. 65:563-566. ,
67. Thiede M.A., S.L. Smock, D.N. Petersen, W.A. Grasser, D.D. Thompson, and S.K. Nishimoto. 1994. Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets. Endocrinology. 135:929-937 .
68. Glowacki, J., and J.B. Lian. 1987. Impaired recruitment and differentiation of osteoclast progenitors by osteocalcin-deplete bone implants. Cell Differ. 21:247-254.